BioVeda Capital logo

BioVeda Capital

Asia, Central Region, Singapore, Singapore

Description

BioVeda is a Singapore based firm. They invest in companies in the healthcare sector with leading market positions, proprietary

Investor Profile

BioVeda Capital has made 8 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series A (25%)
  • Series D (13%)
  • Series C (13%)

Country Focus

  • United States (75%)
  • Singapore (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Clinical Trials
  • Medical Device
  • Chatbot
  • Enterprise Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioVeda Capital frequently co-invest with?

H&
North America, Massachusetts, United States, Boston
Co-Investments: 2
Ventana Capital Management
North America, California, United States, Rancho Santa Margarita
Co-Investments: 2
RBC
North America, Ontario, Canada, Toronto
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Aberdare Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Pacific Rim Ventures
North America, California, United States, San Francisco
Co-Investments: 1
JAFCO Asia
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 2
Venrock
North America, California, United States, Palo Alto
Co-Investments: 2

What are some of recent deals done by BioVeda Capital?

Sensely

San Francisco, California, United States

Sensely is a software developer and chatbot-based platform designed to assist insurance plan members and patients.

ChatbotEnterprise SoftwareHealth CareInformation ServicesInternet
Series BFeb 14, 2017
Amount Raised: $8,000,000
ASLAN Pharmaceuticals

Singapore, Central Region, Singapore

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series BOct 10, 2013
Amount Raised: $22,000,000
Idun Pharmaceuticals

San Diego, California, United States

IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control

BiopharmaBiotechnologyTherapeutics
Series BJun 15, 2004
Amount Raised: $27,000,000
Idun Pharmaceuticals

San Diego, California, United States

IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control

BiopharmaBiotechnologyTherapeutics
Series ADec 9, 2002
Amount Raised: $22,800,000
MerLion Pharma

Singapore, Central Region, Singapore

MerLion Pharmaceuticals is a drug discovery and development company that researches and develops natural products.

BiotechnologyPharmaceutical
Series AOct 30, 2002
Amount Raised: $13,500,000
Dynavax Technologies

Berkeley, California, United States

Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.

BiopharmaBiotechnologyClinical TrialsHealth CareMedical Device
Series DApr 25, 2002
Amount Raised: $34,800,000
Renovis

South San Francisco, California, United States

Renovis,is a biopharmaceutical company developing drugs to treat neurological diseases and disorders.

Innovation ManagementMedicalProfessional Services
Series BJan 10, 2002
Amount Raised: $34,300,000
NewBiotics

San Diego, California, United States

NewBiotics' strategy is to transform drug resistance into therapeutic advantage.

Health CareMedicalTherapeutics
Series CJul 25, 2001
Amount Raised: $11,000,000